| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5595650 | The American Journal of the Medical Sciences | 2017 | 18 Pages |
Abstract
In a cohort of subclinical hypothyroid individuals, the presence of MIA predicts increased risk of CVM as compared to nonmicroalbuminurics with SCH. Further randomized trials are needed to assess the benefits of treating microalbuminuric subclinical hypothyroid individuals and impact on CVM.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tushar A. MD, Maithili MD, MPH, Kevin MD, Abhishek MD, Sadip MD, Anthony MD, Luis MD,